

The Dow Jones index gained over 300 points, with the S&P 500 and NASDAQ also rising. Cintas Corp posted strong earnings and raised its forecast, while...
You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.
Other companies in Anavex Life Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Anavex Life Sciences has a consensus price target of $30.00.
The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $1.34 last updated October 28, 2026 at 9:24 AM EDT.
There are no upcoming dividends for Anavex Life Sciences.
Anavex Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Anavex Life Sciences.
Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data...